Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma

Kim Hoon Yub, Park Woong-Yang, Lee Kyu Eun, Park Won Seo, Chung Yoo Seung, Cho Su Jin, Youn Yeo-Kyu

Year : 2010| Volume: 6| Issue : 4 | Page no: 452-457

   This article has been cited by
 
1 Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
Canhua Yun, Meiling Wu, Juan Xiao, Yong Liu, Wei Zhang, Jingjia Cao
Cancer Management and Research. 2021; Volume 13: 1427
[Pubmed]  [Google Scholar] [DOI]
2 Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma
Young Shin Song, Byung-Hee Kang, Seungbok Lee, Seong-Keun Yoo, Young Sik Choi, Jungsun Park, Dong Yoon Park, Kyu Eun Lee, Jeong-Sun Seo, Young Joo Park
Cancers. 2020; 12(5): 1345
[Pubmed]  [Google Scholar] [DOI]
3 RETRACTED ARTICLE: Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer
Hong Gao, Xiaosong Sun, Hongdong Wang, Ying Zheng
Cell Cycle. 2020; 19(10): 1186
[Pubmed]  [Google Scholar] [DOI]
4 MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4
Zhenzhong Fa, Zhenyu Min, Jianjun Tang, Chuanlei Liu, Guodu Yan, Jianbo Xi
Experimental and Therapeutic Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 MicroRNA-766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
Jianjie Zhao, Zhirong Li, Yi Chen, Shu Zhang, Lingji Guo, Bo Gao, Yan Jiang, Wuguo Tian, Shuai Hao, Xiaohua Zhang
International Journal of Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Prognostic biomarkers in thyroid cancer
Paula Soares,Ricardo Celestino,Miguel Melo,Elsa Fonseca,Manuel Sobrinho-Simões
Virchows Archiv. 2014;
[Pubmed]  [Google Scholar] [DOI]
7 Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
M. Tarabichi,A. Antoniou,M. Saiselet,J. M. Pita,G. Andry,J. E. Dumont,V. Detours,C. Maenhaut
Cancer and Metastasis Reviews. 2013;
[Pubmed]  [Google Scholar] [DOI]
8 Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
Kunavisarut, T. and Kak, I. and MacMillan, C. and Ralhan, R. and Walfish, P.G.
BMC Cancer. 2012; 12(523)
[Pubmed]  [Google Scholar]
9 The surgical management of papillary thyroid microcarcinoma: A 162-month single-center experience of 273 cases
He, Q. and Zhuang, D. and Zheng, L. and Fan, Z. and Zhou, P. and Lv, Z. and Chai, J. and Duan, S.
American Surgeon. 2012; 78(11): 1215-1218
[Pubmed]  [Google Scholar]
10 The Surgical Management of Papillary Thyroid Microcarcinoma: A 162-Month Single-Center Experience of 273 Cases
Qingqing He, Dayong Zhuang, Luming Zheng, Ziyi Fan, Peng Zhou, Zhen Lv, Jixin Chai, Songjian Duan
The American Surgeon. 2012; 78(11): 1215
[Pubmed]  [Google Scholar] [DOI]
11 Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
Tada Kunavisarut,Ipshita Kak,Christina MacMillan,Ranju Ralhan,Paul G Walfish
BMC Cancer. 2012; 12(1): 523
[Pubmed]  [Google Scholar] [DOI]
12 Thyroid oncology
Bugalho, M.J.M. and Wohllk, N. and Hoff, A.O. and Cabanillas, M.E.
Journal of Thyroid Research. 2011; 2011(467570)
[Pubmed]  [Google Scholar]
13 Thyroid Oncology
Maria João M. Bugalho,Nelson Wohllk,Ana O. Hoff,Maria E. Cabanillas
Journal of Thyroid Research. 2011; 2011: 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article